SKL15508
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SKL15508, covering 2016-10-13 to 2016-10-13. Get the full timeline:
Most recent: Clinical Trial Update: A Safety, Tolerability, PK and PD Study of Multiple Oral Doses of SKL15508 in Subjects With Stable Schizophrenia [Phase 1, Phase 2]